| Wednesday, June 20, 2012 | | | | |
Fourth Annual ADAPT Congress 2012 Renaissance Washington, DC Downtown September 19 - 21, 2012
This year, the coverage has been expanded to seven concurrent tracks, focusing on
(1) strategies to accelerate and de-risk drug and diagnostic development (2) implementing personalized medicine though drug-diagnostic co-development; and (3) innovative non-invasive diagnostics for cancer and other diseases.
For more information visit: www.ADAPTcongress.com. | | | Post Master's Graduate Certificate in Sequence Analysis and Genomics
This new certificate is targeted at scientists who already have grounding in biochemistry, molecular biology and cell biology and but need the bioinformatics skills to design experiments and analyze data. The program introduces students to the foundations of bioinformatics through the core bioinformatics courses and then the students take upper level courses that are required for understanding and performing sequence and genomic analysis. This program will be offered online and onsite.
Please click here for more information. | | | • BioMidwest (Indianapolis, Indiana)
Eli Lilly and Company Associate Consultant - Clinical Trial Management Plans and executes trial-level project management activities for assigned studies including trial-level timelines, risk assessment, mitigation plans, and other aspects of trial-level project management (e.g. budget, grants, metrics).
• Biotech Beach (Santa Barbara, California)
Allergan Inc. Senior Clinical Safety Scientist Responsible for the proactive safety strategy and all medical safety aspects of a medical device including medical risk management for assigned development of marketed products and clinical studies.
• Biotech Bay (South San Francisco, California)
Johnson & Johnson Family of Companies Director, Clinical Operations Provides input to clinical development plans and manages their implementation in conformance to all relevant laws, regulations, guidelines, policies and procedures through the team of Clinical Operations staff.
• Genetown (Cambridge, Massachusetts)
Novartis Institutes for BioMedical Research, Inc. Clinical Data Analyst Will provide real-time data visualization and analysis for clinical studies; facilitate data integration and 'best practice' visualization within clinical trials; propose and support the imple-mentation of new technologies that can deliver enhanced clinical trials and more efficient internal processes.
• BioCapital (Bethesda, Maryland)
SAIC-Frederick, Inc. Clinical Project Manager II Will work with Protocol Navigators (PNs) and medical staff to ensure protocols are consistent with policies that govern human subject's research. This CPM II is responsible for managing and coordinating associated regulatory activities, protocol writing support and providing expert level of regulatory guidance to Principal Investigators (PIs),
• Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! | | Job seekers can spend days with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in various regions across the U.S.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
More information about BioSpace's Career Fairs
BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services | | | |
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! | Biomarkers in Late Stage Clinical Trials
• Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis.
Click Here for More Information. | | | Hot Company
Cerulean Pharma Inc. 840 Memorial Drive, 5th Floor Cambridge, Massachusetts 02139 U.S.A. Phone: 617-551-9600 Fax: 617-494-1544
Cerulean was founded in 2006 and is advancing nanopharmaceuticals as a new class of tumor-targeted cancer therapy aimed to improve clinical outcomes. Cerulean's tumor-targeted nanopharmaceuticals are designed to address therapeutic hurdles in cancer by selectively targeting therapy to diseased tissues.
More Company Profiles | | Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 | ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 | Send questions and comments to the ClinicaSpace News Beat Team.
Editor & Publisher: Lana Ho Editorial & Production Staff: Maysa Darwish, Tammy Liu
ClinicaSpace.com - Clinical Trials. Clinical Research. Community. | | • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | | | | | | |
No comments:
Post a Comment